Client Request A leading global biopharmaceutical company approached CSI with an urgent need for the Fluarix QIV Southern Hemisphere Vaccine 2025. The requirements included: Quantity: 10,000 doses Delivery Date: As soon as possible (urgent) Delivery Location: Singapore Batch Preference: Multiple lots acceptable if necessary The Challenge The client was let down by a supplier in Brazil and needed to secure alternative stock at the last minute. Complicating matters, the Fluarix